VYKAT XR

Formula & Concentration

VYKAT XR – diazoxide choline tablet, film-coated

Manufacturer

Soleno Therapeutics Inc.

Indications

VYKAT XR is indicated for the treatment of hyperphagia in adults and pediatric patients 4 years of age and older with Prader-Willi syndrome (PWS). (1)

Product Options

Package Size

NDC #

Presentation

25 mg

83860-0025-01

Tablet

75 mg

83860-0075-01

Tablet

150 mg

83860-0150-01

Tablet

Shelf Life and Storage

Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15° and 30°C (59° and 86°F) [see USP Controlled Room Temperature].

Keep in tightly closed container. Protect from humidity. Do not remove desiccant.